MetaVia is trading at $1.46, up +8.96% in after-hours trading, with no verified catalyst identified.
- No company announcement dated October 8 was listed; its latest listed release was September 9.
- The gain runs counter to the mildly lower major indexes supplied for the session; no direct link is established.
- No verified catalyst or volume information was available. The September release covered preclinical findings for DA-1726, not a new October 8 event.